We are live on ! Find out more
DS

DRW Securities Portfolio holdings

AUM $7.21B
1-Year Est. Return 20.54%
This Fund
S&P 500
This Quarter Est. Return
+6.87%
1 Year Est. Return
+20.54%
3 Year Est. Return
+87.88%
5 Year Est. Return
+88.87%
10 Year Est. Return
+277.95%
AUM
$324M
AUM Growth
-$249M
Cap. Flow
-$260M
Cap. Flow %
-80.01%
Top 10 Hldgs %
88.48%
Holding
98
New
27
Increased
13
Reduced
11
Closed
34

Top Buys

Rank Stock Value
1
TQQQ icon
ProShares UltraPro QQQ
TQQQ
+$12.7M
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$11.4M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$10.5M
4
QLD icon
ProShares Ultra QQQ
QLD
+$8.14M
5
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$4.15M

Top Sells

Rank Stock Value
1
GLD icon
SPDR Gold Trust
GLD
+$36.5M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$13.2M
3
SHV icon
iShares 0-1 Year Treasury Bond ETF
SHV
+$3.11M
4
QID icon
ProShares UltraShort QQQ
QID
+$2.75M
5
SH icon
ProShares Short S&P500
SH
+$2.56M

Sector Composition

Rank Sector Weight
1 Healthcare 1.16%
2 Consumer Discretionary 0.13%
3 Communication Services 0.1%
4 Financials 0.1%
5 Technology 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGMO
51
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$150K 0.05%
+10,000
New +$111K
HZNP
52
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$148K 0.05%
+11,700
New +$149K
ESI icon
53
PUT
Element Solutions
ESI
$9.12B
$119K 0.04%
+10,700
New +$133K
ESI icon
54
Element Solutions
ESI
$9.12B
$118K 0.04%
+10,600
New +$131K
ICAD
55
DELISTED
iCAD Inc
ICAD
$117K 0.04%
26,500
+11,256
+74% +$43.1K
KDNY
56
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$107K 0.03%
+2,000
New +$119K
ALDX icon
57
Aldeyra Therapeutics
ALDX
$91.7M
$86K 0.03%
+12,000
New +$62.7K
CCO icon
58
Clear Channel Outdoor Holdings
CCO
$1.23B
$72K 0.02%
+15,558
New +$68.2K
CTIC
59
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$53K 0.02%
+16,561
New +$55.3K
SRRA
60
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$39K 0.01%
625
– –
LRMR icon
61
Larimar Therapeutics
LRMR
$416M
$35K 0.01%
833
– –
RVP icon
62
Retractable Technologies
RVP
$20.4M
$30K 0.01%
45,600
– –
GERN icon
63
Geron
GERN
$911M
$22K 0.01%
10,000
– –
ECYT
64
DELISTED
Endocyte, Inc. Common Stock
ECYT
$16K ﹤0.01%
11,000
– –
AZN icon
65
CALL
AstraZeneca
AZN
$263B
– –
-27,250
Closed -$1.86M
BG icon
66
CALL
Bunge Global
BG
$23.6B
– –
-7,700
Closed -$574K
BIIB icon
67
PUT
Biogen
BIIB
$29.9B
– –
-1,000
Closed -$240K
BND icon
68
Vanguard Total Bond Market
BND
$157B
– –
-28,329
Closed -$2.32M
BMY icon
69
CALL
Bristol-Myers Squibb
BMY
$127B
– –
-14,000
Closed -$780K
DECK icon
70
CALL
Deckers Outdoor
DECK
$13.3B
– –
-133,200
Closed -$1.51M
GSAT icon
71
CALL
Globalstar
GSAT
$10.2B
– –
-2,800
Closed -$89K
GSK icon
72
CALL
GSK
GSK
$103B
– –
-34,000
Closed -$1.83M
HOG icon
73
CALL
Harley-Davidson
HOG
$2.68B
– –
-13,300
Closed -$718K
IGSB icon
74
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$22.8B
– –
-9,858
Closed -$519K
IVV icon
75
iShares Core S&P 500 ETF
IVV
$876B
– –
-54,352
Closed -$13.2M
1 2
3
4

Similar funds

CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
FPP
Findlay Park Partners London, United Kingdom $7.17B AUM 17.27% 1-Year Est. Return
UB
UMB Bank Kansas City, Missouri $7.16B AUM 20.88% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $7.13B AUM 35.47% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

DRW Securities's Q3 2017 Portfolio in Review

As of Q3 2017, DRW Securities held 98 positions worth $324M, down 43% from $573M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

DRW Securities withdrew a net $260M in Q3 2017, closing 34 positions and reducing 11 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $13.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 1.2% of assets, up from 0.21% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, DRW Securities opened a new position in ProShares UltraPro QQQ worth $13.2M.

  • DRW Securities's largest Q3 2017 buy was ProShares UltraPro QQQ: 2,768,544 shares worth $13.2M.
  • DRW Securities added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $11.4M increase.
  • DRW Securities's biggest Q3 2017 reduction was SPDR Gold Trust, cutting an estimated $36.5M.
  • DRW Securities fully exited iShares Core S&P 500 ETF in Q3 2017, selling an estimated $13.2M.
  • DRW Securities's ten largest holdings make up 88% of its $324M portfolio in Q3 2017.
  • DRW Securities opened 27 new positions and closed 34 in Q3 2017.
  • DRW Securities's portfolio value fell 43% quarter-over-quarter to $324M.

Based on DRW Securities's 13F filing for Q3 2017, filed 14 Nov 2017.